« Back to guidelines under development

Pharmacologic Reversal of Direct Oral Anticoagulants2020

Type: New Practice Management Guideline (PMG)
Category: Surgical Critical Care
Committee Liaison: Rachel S. Morris, MD, FACS

Team leader(s)

Use of oral anticoagulants is ubiquitous with increasing use of direct oral anticoagulants (DOACs) in lieu of warfarin. As well, there are many options for reversal of these agents. Yet, there are no PMGs related to which reversal agent to use. A PMG is needed to guide therapy for warfarin, dabigatran, and oral Xa inhibitors.

Work Group Member:
Michael Smith, MD
Nimitt Patel, MD
Bill Chiu, MD, FACS, FCCM
Karen Wanersdorfer, DO
Tom Harrod
Lindsay Kranker, MD
Kaushik Mukherjee, MD, MSCI, FACS

« Back to guidelines under development